Understanding PFAS MCL: Implications for Water Quality and Public Health

Introduction

The prevalence of per- and polyfluoroalkyl substances (PFAS) in the environment has sparked considerable alarm among water quality regulators, plant operators, and public health advocates. As of July 2025, the establishment of Maximum Contaminant Levels (MCLs) for these substances in drinking water remains pivotal in mitigating public health risks. With regulatory agencies such as the Environmental Protection Agency (EPA) tightening standards, understanding the nuances surrounding PFAS MCL is essential for professionals involved in water treatment and environmental management. This article delves into the regulatory landscape, health implications, and emerging challenges associated with PFAS MCL, offering an authoritative analysis for stakeholders in the field. The wider framework is covered in our overview of PFAS federal regulations, and the rulemaking itself in our guide to the EPA PFAS rule.

The PFAS Landscape

What are PFAS?

PFAS, often dubbed “forever chemicals” due to their persistent nature in the environment, include a wide range of synthetic chemicals used in various industrial and consumer applications. These chemicals are commonly found in firefighting foams, non-stick cookware, stain-resistant fabrics, and even food packaging. Their widespread use has led to contamination of water supplies, which is particularly alarming given their resistance to degradation.

Historical Context and Regulatory Changes

The regulatory landscape for PFAS has evolved rapidly over the past decade. Historically, PFAS were largely unregulated, but mounting evidence of their health effects has led to increased scrutiny. Significant milestones include:

• The introduction of the PFAS Action Plan by the EPA in 2019.
• The 2022 interim health advisories for PFOA and PFOS, which were non-enforceable.
• The final National Primary Drinking Water Regulation of April 2024, which established the first enforceable federal MCLs for PFAS, followed by EPA’s announced reconsideration of parts of that rule in 2025.

Current PFAS MCL Standards

Review of MCLs Set by the EPA

As of mid-2025, the EPA has finalized MCLs for various PFAS chemicals. This includes:

• PFOA: 4.0 parts per trillion (ppt), equivalently 4.0 nanograms per liter or 0.004 micrograms per liter
• PFOS: 4.0 ppt
• PFHxS: 10 ppt
• PFNA: 10 ppt
• HFPO-DA (GenX chemicals): 10 ppt
• Mixtures: a Hazard Index of 1 applies to combinations of PFHxS, PFNA, HFPO-DA, and PFBS. PFBS is regulated only through this mixture calculation and has no individual MCL.

The unit conversion is worth stating explicitly because it is a frequent source of error by a factor of a thousand: 4.0 ppt equals 4.0 ng/L equals 0.004 µg/L. A figure written as “0.004 ppt” is a misstatement of the µg/L value and is one thousand times stricter than the actual standard.

EPA also set Maximum Contaminant Level Goals of zero for PFOA and PFOS. MCLGs are non-enforceable health targets rather than compliance limits; the enforceable numbers are the MCLs above. These limits replaced the 2022 interim health advisories of 0.004 ppt for PFOA and 0.02 ppt for PFOS, which were advisory rather than enforceable. In May 2025 EPA announced it intended to retain the PFOA and PFOS limits while reconsidering the others and extending compliance deadlines, so the status of the 10 ppt limits and the Hazard Index should be verified against EPA’s current published rule before being relied on.

State-Level Regulations

In addition to federal regulations, several states have enacted their own PFAS regulations, which sometimes set even stricter MCLs than those established by the EPA. For example:

• California uses notification and response levels rather than MCLs for PFOA and PFOS, set in the single-digit to low-tens of parts per trillion, which trigger reporting and potential source removal rather than a numerical violation.
• Michigan adopted enforceable state drinking water standards for seven PFAS compounds in 2020, several of which preceded the federal limits.
• New Jersey, New York, Massachusetts, and several other states set enforceable limits ahead of EPA, which is why some utilities were already treating before the federal rule existed.

These state initiatives can create a patchwork regulatory framework that complicates compliance efforts for municipalities operating in multiple jurisdictions.

Health Implications of PFAS Exposure

Adverse Health Effects

Research studies have established connections between PFAS exposure and a range of adverse health outcomes, including:

• Cancer: Increased rates of kidney and testicular cancer have been linked to PFAS.
• Liver damage: PFAS exposure may lead to elevated liver enzymes and liver disease.
• Thyroid hormone disruption: PFAS can interfere with thyroid function, affecting metabolism and growth.

Recent epidemiological studies reaffirm these concerns, indicating a pressing need for stricter regulatory measures.

Vulnerable Populations

Vulnerable populations, including children and pregnant women, may be particularly at risk from PFAS exposure. Studies have shown that PFAS can cross the placental barrier, potentially leading to developmental issues in fetuses.

Moreover, communities situated near manufacturing sites or military bases using PFAS-containing firefighting foam face heightened risks, with historically poor access to clean water exacerbating the situation.

Technological Solutions for PFAS Removal

Conventional Water Treatment Methods

Conventional treatment does not remove PFAS. Coagulation, sedimentation, sand filtration, chlorination, and ozonation are all essentially ineffective, and oxidation can transform precursor compounds into terminal PFAS, raising measured concentrations rather than lowering them. Only adsorption onto carbon or resin, or membrane separation, achieves meaningful removal, which is why compliance generally requires adding a process rather than optimizing an existing one.

Advanced Treatment Technologies

Emerging technologies are proving effective in reducing PFAS levels to meet the new MCLs, including:

• Granular Activated Carbon (GAC): Widely used for PFAS adsorption.
• Reverse Osmosis (RO): Effective for removing a broad range of PFAS compounds.
• Ion Exchange: This method has shown promise in specifically targeting and removing PFAS.

Case studies demonstrate that facilities implementing these advanced technologies have successfully complied with the MCL requirements, highlighting their importance in future water treatment strategies.

Implementation and Compliance Challenges

Monitoring and Testing

Effective monitoring and testing for PFAS levels in drinking water remain significant challenges. Current testing protocols often lag behind regulatory changes, resulting in insufficient data about PFAS prevalence in many systems.

• Monitoring gaps: Many smaller municipalities lack the resources to conduct regular testing.
• Compliance complexities: Navigating the new regulatory frameworks can be daunting for many local authorities. Obligations on manufacturers and importers under TSCA section 8(a)(7) are separate from drinking water compliance and are covered in our guide to the PFAS reporting rule.

Financial Implications

The financial burden of implementing PFAS monitoring and treatment solutions can be extensive. Capital costs for a municipal-scale treatment installation commonly fall in the low millions and scale with design flow rather than with PFAS concentration, while operating cost scales with concentration through media changeout frequency. A frequently overlooked line is residuals: spent carbon, spent resin, and membrane concentrate all carry the removed PFAS and incur their own disposal cost.

However, funding opportunities exist at both state and federal levels, with programs designed to assist municipalities facing these challenges.

Future Outlook and Recommendations

Continued Research Needs

Ongoing research is critical to deepen our understanding of PFAS health impacts. More data will play a vital role in adjusting MCLs and developing innovative technologies for removal and treatment.

Strategic Recommendations for Stakeholders

• Invest in Advanced Treatment Solutions: Municipalities should prioritize investment in technologies that efficiently remove PFAS to achieve compliance with MCLs.
• Enhance Monitoring Programs: Conduct regular assessments and document findings meticulously to ensure informed management practices.
• Community Engagement: Public transparency surrounding PFAS risks and management efforts will cultivate trust and inform citizens about health recommendations.

Conclusion

As the landscape of PFAS regulation continues to evolve, staying informed and proactive is essential for all stakeholders involved in water management. The establishment of Maximum Contaminant Levels for PFAS signifies a critical step towards safeguarding public health, but it also presents challenges that require immediate attention and action. By adopting advanced treatment technologies and ensuring comprehensive oversight, municipalities can protect their communities and navigate the complexities of regulatory compliance effectively. As we look to the future, collaboration between regulatory bodies, researchers, and water utilities will be crucial in addressing the ongoing challenges posed by PFAS.